Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Edward W. Richmond who wrote (789)	5/20/1998 4:53:00 PM
From: SOROS	Read Replies (2) \| Respond to of 1185

I believe we have finally lost both the irrational traders and the scared money. Now, Nortran will begin to reward the rational, cool-headed investors that do understand their company (contrary to what Mr. Forthright says). I feel good now. I remain, SOROS

To: Edward W. Richmond who wrote (789)	5/20/1998 7:49:00 PM
From: Wisee	Read Replies (2) \| Respond to of 1185

Ed, I haven't seen the latest Investor's Digest, but Michael states that Golden Capital and not Gordon Capital has put out the buy recommendation on Nortran. I suspect Gordon Capital will also put out a buy recommendation shortly.

To: Edward W. Richmond who wrote (789)	5/20/1998 10:11:00 PM
From: Michael M. Cubrilo	Respond to of 1185

Edward, it is difficult to time the market if not impossible. However, on any speculative issue, and I still consider NRT speculative, how much profit is enough? A 100% gain in about 6 months is pretty good and calls for me to take money off the table, but not all. That is why I maintained my 30% core position in NRT right up to the news. But when a stock turns sour as fast as NRT did, I will bail and look for another re-entry point. I do plan to re-enter for the longer term once again. It is "free money" now. However, scanning these threads also reveals many other buses. I do not consider GIB.a speculative, and yet look at the returns that stock has provided shareholders. It recently split 2 for 1 (yesterday). This is the 3rd time in 9 months that the stock has split 2 for 1. Now THAT is what I call exceptional shareholder return. I am impressed with NRT's management & accomplishments thus far. I hope they have marketable drugs before the baby boomers all retire! mike